Delay in adjuvant radiation treatment and outcomes of breast cancer - A review

Breast Cancer Research and Treatment

Volumn 74, Issue 1, 2002, Pages 77-94

  Hebert Croteau N ^a,b   Freeman, C R ^c   Latreille, J ^b   Brisson, J ^a,d  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b HÔPITAL CHARLES LEMOYNE   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

Breast neoplasms; Combined modality therapy; Radiotherapy; Time factors; Treatment delay

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PREDNISONE; TAMOXIFEN; VINCRISTINE; ANTINEOPLASTIC AGENT;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVIEW; TREATMENT OUTCOME; ADJUVANT THERAPY; ADULT; AGED; BREAST TUMOR; FEMALE; MIDDLE AGED; PATHOLOGY; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SURVIVAL; TIME; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMAN; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SURVIVAL; TIME FACTORS; HUMANS; MIDDLE AGED;

EID: 0035988001     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016089215070     Document Type: Review

References (43)

1. Treatment of early-stage breast cancer
2. Meeting highlights: A reappraisal of research results for the local treatment of early stage breast cancer
3. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology
4. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy
5. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
6. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
7. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCCG 82c randomised trial
8. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis
9. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials
10. Integration of conservative surgery, radiotherapy, and chemotherapy for treatment of early-stage, node-positive breast cancer: Sequencing, timing, and outcome
11. Influence du délai entre la chirurgie et l'irradiation locorégionale sur l'évolution des cancers du sein N+ non métastatiques. Une étude du groupe des radiothérapeutes de la fédération nationale des centres de lutte contre le cancer
12. Sequencing of chemotherapy and radiation in lymph-node negative breast cancer
13. The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer
14. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer
15. Analysis of loco-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave-Roussy
16. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy
17. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?
18. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence
19. Two months of doxorubicin-cyclophosphamide with and without reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: Results from the National Surgical Adjuvant Breast and Bowel Project B-15
20. Timing of radiotherapy and chemotherapy following breast conserving surgery for patients with node-positive breast cancer
21. The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery
22. Effect of delay in radiation in the combined modality treatment of breast cancer
23. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence
24. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?
25. Effect of delayed radiation therapy on local control in breast conservation therapy
26. Radiotherapy with and without chemotherapy after breast conservation surgery for early stage breast cancer: A review of timing
27. Analysis of outcomes for high-risk breast cancer based on interval from surgery to postmastectomy radiation therapy
28. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer
29. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence
30. Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences
31. Laboratory and clinical research in breast cancer - A personal adventure: The David A. Karnofsky Memorial Lecture
32. Natural history of small breast cancers
33. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes
34. Polychemotherapy for early breast cancer: An overview of the randomised trials
35. Tamoxifen for early breast cancer: An overview of the randomised trials
36. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy
37. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Study Group
38. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group
39. Adjuvant therapy for breast cancer
40. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy
41. Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer
42. Concurrent CMF and radiation therapy for early stage breast cancer: Results of a pilot study
43. Sequencing of irradiation and chemotherapy for early-stage breast cancer